S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Baxter Completes Enrollment in Phase III Clinical Trial of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A (2013/11/13)|
|Baxter and Coherus Biosciences Announce Collaboration to Develop and Commercialize Biosimilars ()|
|Baxter Completes Acquisition of Gambro AB and Enhances Global Leadership in Renal Therapies (2013/9/6)|
|Baxter and JW Holdings Announce Exclusive Global Development and Commercialization Collaboration for Omega 3 Parenteral Nutrition Products ()|
|Baxter 3rd-Quarter Profit Down 6.7 % On Expenses Tied to Gambro Acquisition ()|
|Baxter Profit Falls on Acquisition Costs -- Update ()|
|Baxter Promotes Wellness, Inclusion and Diversity among Its Employees, is Recognized for Ongoing Sustainability Efforts (2013/10/21)|
|Baxter and Cell Therapeutics Announce Worldwide Strategic Collaboration to Develop and Commercialize Pacritinib (2013/11/15)|
|Baxter Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union (2013/10/23)|
|Baxter Submits Application for European Approval of RIXUBIS, Recombinant Factor IX (nonacog gamma) for Hemophilia B (2013/10/31)|
Click above to view more mutual fund data and stats for bax - Baxter International Inc..